Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 207 articles:
HTML format



Single Articles


    July 2021
  1. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    PubMed     Abstract available


  2. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    PubMed    


  3. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed     Abstract available


    June 2021
  4. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed     Abstract available


    May 2021
  5. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed     Abstract available


  6. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    PubMed    


  7. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    PubMed     Abstract available


    April 2021
  8. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    PubMed     Abstract available


    March 2021
  9. O'SHEA A, Pierce TT
    US Elastography in Hepatic Fibrosis-Radiology In Training.
    Radiology. 2021 Mar 23:203893. doi: 10.1148/radiol.2021203893.
    PubMed     Abstract available


  10. BAE JS, Lee JM, Yoon JH, Kang HJ, et al
    Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Radiology. 2021 Mar 2:203537. doi: 10.1148/radiol.2021203537.
    PubMed     Abstract available


    February 2021
  11. PALTIEL HJ
    LI-RADS Version 2018 Is of Limited Use in the Diagnosis of Hepatocellular Carcinoma in Children.
    Radiology. 2021 Feb 23:204480. doi: 10.1148/radiol.2021204480.
    PubMed    


  12. KHANNA G, Chavhan GB, Schooler GR, Fraum TJ, et al
    Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Radiology. 2021 Feb 23:203559. doi: 10.1148/radiol.2021203559.
    PubMed     Abstract available


  13. NARDELLI S, Riggio O, Turco L, Gioia S, et al
    Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Radiology. 2021 Feb 2:203051. doi: 10.1148/radiol.2021203051.
    PubMed     Abstract available


    January 2021
  14. KARMEGARAJ B
    Normal Fetal Umbilical, Portal, and Hepatic Venous System: Four-dimensional STIC Rendering.
    Radiology. 2021 Jan 26:203300. doi: 10.1148/radiol.2021203300.
    PubMed     Abstract available


  15. MADOFF DC, Cornman-Homonoff J, Fortune BE, Gaba RC, et al
    Management of Refractory Ascites Due to Portal Hypertension: Current Status.
    Radiology. 2021 Jan 26:201960. doi: 10.1148/radiol.2021201960.
    PubMed     Abstract available


  16. CHEN S, Peng Z, Zhang Y, Chen M, et al
    Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Radiology. 2021 Jan 19:202289. doi: 10.1148/radiol.2021202289.
    PubMed     Abstract available


  17. KIESSLING F
    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    PubMed    


  18. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    PubMed     Abstract available


  19. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    PubMed     Abstract available


    December 2020
  20. EISENBREY JR, Forsberg F, Wessner CE, Delaney LJ, et al
    US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
    Radiology. 2020 Dec 15:202321. doi: 10.1148/radiol.2020202321.
    PubMed     Abstract available


    November 2020
  21. ROSTAMBEIGI N, Farsad K, Young S, Shrestha P, et al
    Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Radiology. 2020 Nov 17:201690. doi: 10.1148/radiol.2020201690.
    PubMed     Abstract available


  22. GUPTA I, Eisenbrey JR, Machado P, Stanczak M, et al
    Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.
    Radiology. 2020 Nov 17:202677. doi: 10.1148/radiol.2020202677.
    PubMed     Abstract available


  23. FRULIO N, Balabaud C, Trillaud H, Bioulac-Sage P, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Nov 10:203244. doi: 10.1148/radiol.2020203244.
    PubMed    


  24. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    PubMed    


    October 2020
  25. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    PubMed    


  26. BASHIR MR
    Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Radiology. 2020 Oct 6:203631. doi: 10.1148/radiol.2020203631.
    PubMed    


  27. NAKAI Y, Gonoi W, Kurokawa R, Nishioka Y, et al
    MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Radiology. 2020 Oct 6:202367. doi: 10.1148/radiol.2020202367.
    PubMed     Abstract available


  28. DAVARPANAH AH, Eberhardt LW
    Case 282: Fishbone Pylephlebitis.
    Radiology. 2020;297:239-243.
    PubMed     Abstract available


  29. DE ROOS A, Lamb HJ
    Exploring the Interaction between Liver and Heart Disease.
    Radiology. 2020;297:62-63.
    PubMed    


  30. WEISS CR, Nezami N
    One Step Closer to Precision Medicine for Transarterial Therapy of HCC.
    Radiology. 2020;297:235-236.
    PubMed    


    September 2020
  31. TANG A
    Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:203376. doi: 10.1148/radiol.2020203376.
    PubMed    


  32. WANG F, Numata K, Ruan L
    Accurate Assessment of Vascularity of Focal Hepatic Lesions in Arterial Phase Imaging.
    Radiology. 2020 Sep 29:202780. doi: 10.1148/radiol.2020202780.
    PubMed    


  33. MIN JH, Lee MW, Park HS, Lee DH, et al
    Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:201940. doi: 10.1148/radiol.2020201940.
    PubMed     Abstract available


  34. DO RK, Mendiratta-Lala M
    Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
    Radiology. 2020;296:562-563.
    PubMed    


  35. SOFOCLEOUS CT, Vasiniotis Kamarinos N
    Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
    Radiology. 2020;296:685-686.
    PubMed    


    August 2020
  36. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 25:209017. doi: 10.1148/radiol.2020209017.
    PubMed    


  37. ISAAK A, Praktiknjo M, Jansen C, Faron A, et al
    Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis.
    Radiology. 2020 Aug 18:201057. doi: 10.1148/radiol.2020201057.
    PubMed     Abstract available


  38. ZIV E, Zhang Y, Kelly L, Nikolovski I, et al
    NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.
    Radiology. 2020 Aug 11:200201. doi: 10.1148/radiol.2020200201.
    PubMed     Abstract available


  39. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 4:200115. doi: 10.1148/radiol.2020200115.
    PubMed     Abstract available


  40. KIM TK, Jang HJ
    Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Radiology. 2020 Aug 4:202763. doi: 10.1148/radiol.2020202763.
    PubMed    


    July 2020
  41. PARK S, Joo I, Lee DH, Bae JS, et al
    Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Radiology. 2020 Jul 21:192797. doi: 10.1148/radiol.2020192797.
    PubMed     Abstract available


  42. SAVIC LJ, Doemel LA, Schobert IT, Montgomery RR, et al
    Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Radiology. 2020 Jul 7:200373. doi: 10.1148/radiol.2020200373.
    PubMed     Abstract available


    June 2020
  43. SCHOOLER GR, Squires JH, Alazraki A, Chavhan GB, et al
    Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
    Radiology. 2020 Jun 30:200751. doi: 10.1148/radiol.2020200751.
    PubMed     Abstract available


  44. HERMANN AL, Dieudonne A, Ronot M, Sanchez M, et al
    Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with (90)Y in the SARAH Study.
    Radiology. 2020 Jun 30:191606. doi: 10.1148/radiol.2020191606.
    PubMed     Abstract available


  45. SUGIMOTO K, Moriyasu F, Oshiro H, Takeuchi H, et al
    The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Jun 23:192665. doi: 10.1148/radiol.2020192665.
    PubMed     Abstract available


  46. BARR RG, Wilson SR, Rubens D, Garcia-Tsao G, et al
    Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement.
    Radiology. 2020 Jun 9:192437. doi: 10.1148/radiol.2020192437.
    PubMed     Abstract available


  47. MOTOSUGI U
    Treat or Wait? Hepatobiliary Phase Hypointense Nodule without Arterial Phase Hyperenhancement.
    Radiology. 2020 Jun 2:201726. doi: 10.1148/radiol.2020201726.
    PubMed    


  48. JOO I, Kim SY, Kang TW, Kim YK, et al
    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Radiology. 2020 Jun 2:192275. doi: 10.1148/radiol.2020192275.
    PubMed     Abstract available


    May 2020
  49. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.
    PubMed    


  50. LOCKHART ME, Smith AD
    Fatty Liver Disease: Artificial Intelligence Takes on the Challenge.
    Radiology. 2020;295:351-352.
    PubMed    


    April 2020
  51. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    PubMed     Abstract available


    March 2020
  52. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    PubMed     Abstract available


  53. VERNUCCIO F, Ronot M, Dioguardi Burgio M, Cauchy F, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Mar 17:191790. doi: 10.1148/radiol.2020191790.
    PubMed     Abstract available


  54. LYSKE J, Hutchinson C, Manolea F, Patel VH, et al
    Case 275: Multiple Hepatic Hydatid Cysts.
    Radiology. 2020;294:716-719.
    PubMed     Abstract available


    February 2020
  55. HAN A, Byra M, Heba E, Andre MP, et al
    Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Radiology. 2020 Feb 25:191160. doi: 10.1148/radiol.2020191160.
    PubMed     Abstract available


  56. KONO Y, Sirlin CB, Fetzer DT, Kim TK, et al
    Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Radiology. 2020 Feb 18:192557. doi: 10.1148/radiol.2020192557.
    PubMed    


  57. KROMREY ML, Le Bihan D, Ichikawa S, Motosugi U, et al
    Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Radiology. 2020 Feb 11:191498. doi: 10.1148/radiol.2020191498.
    PubMed     Abstract available


  58. KIM MJ
    Improving Survival with Gadoxetic Acid-enhanced MRI for Hepatocellular Carcinoma.
    Radiology. 2020 Feb 4:192713. doi: 10.1148/radiol.2020192713.
    PubMed    


  59. HAN A, Zhang YN, Boehringer AS, Montes V, et al
    Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Radiology. 2020 Feb 4:191152. doi: 10.1148/radiol.2020191152.
    PubMed     Abstract available


  60. KANG TW, Kong SY, Kang D, Kang MW, et al
    Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis.
    Radiology. 2020 Feb 4:190639. doi: 10.1148/radiol.2020190639.
    PubMed     Abstract available


  61. DO RK, Mendiratta-Lala M
    LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.
    Radiology. 2020;294:327-328.
    PubMed    


    January 2020
  62. JI GW, Zhu FP, Xu Q, Wang K, et al
    Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Radiology. 2020 Jan 14:191470. doi: 10.1148/radiol.2020191470.
    PubMed     Abstract available


    December 2019
  63. LIAO H, Ahmed M, Markezana A, Zeng G, et al
    Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model.
    Radiology. 2019 Dec 17:191023. doi: 10.1148/radiol.2019191023.
    PubMed     Abstract available


  64. CHAUDHRY M, McGinty KA, Mervak B, Lerebours R, et al
    The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
    Radiology. 2019 Dec 17:191581. doi: 10.1148/radiol.2019191581.
    PubMed     Abstract available


  65. CROCETTI L
    Toward Final Rescue of Contrast-enhanced US for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:192309. doi: 10.1148/radiol.2019192309.
    PubMed    


  66. YOON JH, Lee JM, Chang W, Kang HJ, et al
    Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
    Radiology. 2019 Dec 3:190794. doi: 10.1148/radiol.2019190794.
    PubMed     Abstract available


  67. HUANG JY, Li JW, Lu Q, Luo Y, et al
    Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Dec 3:191086. doi: 10.1148/radiol.2019191086.
    PubMed     Abstract available


  68. KIM KW, Van den Abbeele AD
    Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer.
    Radiology. 2019;293:704-706.
    PubMed    


  69. DURAN R, Namur J, Pascale F, Czuczman P, et al
    Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver Cancer.
    Radiology. 2019;293:695-703.
    PubMed     Abstract available


    November 2019
  70. SIDHU PS
    Using Contrast-enhanced US for Hepatocellular Carcinoma Assessment: Contrast-enhanced US LI-RADS version 2017 Classification Is Diagnostically Accurate.
    Radiology. 2019 Nov 26:192355. doi: 10.1148/radiol.2019192355.
    PubMed    


  71. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    PubMed     Abstract available


    October 2019
  72. VANSONNENBERG E, Mueller PR
    Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding Criteria.
    Radiology. 2019 Oct 22:192151. doi: 10.1148/radiol.2019192151.
    PubMed    


  73. SHI F, Wu M, Lian SS, Mo ZQ, et al
    Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
    Radiology. 2019 Oct 22:181991. doi: 10.1148/radiol.2019181991.
    PubMed     Abstract available


  74. MOTOSUGI U
    Improving Postsurgical Outcome in Patients with HCC by Using a Hepatobiliary Contrast Agent.
    Radiology. 2019 Oct 8:191990. doi: 10.1148/radiol.2019191990.
    PubMed    


  75. KIM DK, An C, Chung YE, Choi JY, et al
    Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
    Radiology. 2019 Oct 8:190414. doi: 10.1148/radiol.2019190414.
    PubMed     Abstract available


  76. MEYER M, Ronald J, Vernuccio F, Nelson RC, et al
    Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.
    Radiology. 2019 Oct 1:190928. doi: 10.1148/radiol.2019190928.
    PubMed     Abstract available


  77. QUAIA E
    State of the Art: LI-RADS for Contrast-enhanced US.
    Radiology. 2019;293:4-14.
    PubMed     Abstract available


    September 2019
  78. GRAFFY PM, Sandfort V, Summers RM, Pickhardt PJ, et al
    Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment.
    Radiology. 2019 Sep 17:190512. doi: 10.1148/radiol.2019190512.
    PubMed     Abstract available


  79. LEE DH, Lee JY, Bae JS, Yi NJ, et al
    Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation.
    Radiology. 2019 Sep 10:190064. doi: 10.1148/radiol.2019190064.
    PubMed     Abstract available


  80. VIJ A, Fetzer DT
    Persistent Heterogeneous Liver Enhancement after US Contrast Material Injection.
    Radiology. 2019;292:539.
    PubMed    


    August 2019
  81. GONSALVES CF, Eschelman DJ, Adamo RD, Anne PR, et al
    A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Radiology. 2019 Aug 27:190199. doi: 10.1148/radiol.2019190199.
    PubMed     Abstract available


  82. ALVES PEREIRA FD, Hickson ML, Wilson PAJ
    Case 268: Bilateral Adrenal Hemorrhage in the Context of Sepsis.
    Radiology. 2019;292:503-506.
    PubMed     Abstract available


    July 2019
  83. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model.
    Radiology. 2019 Jul 23:190115. doi: 10.1148/radiol.2019190115.
    PubMed     Abstract available


  84. WHITE SB
    Treatment of Hepatocellular Carcinoma:Time for a Paradigm Shift?
    Radiology. 2019 Jul 23:191474. doi: 10.1148/radiol.2019191474.
    PubMed    


  85. LEE SM, Lee JM, Ahn SJ, Kang HJ, et al
    LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Radiology. 2019 Jul 16:182867. doi: 10.1148/radiol.2019182867.
    PubMed     Abstract available


  86. PARK JH, Park MS, Lee SJ, Jeong WK, et al
    Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Radiology. 2019 Jul 9:190183. doi: 10.1148/radiol.2019190183.
    PubMed     Abstract available


  87. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019;292:270.
    PubMed    


  88. GERVAIS DA
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:235-236.
    PubMed    


  89. SHROPSHIRE EL, Chaudhry M, Miller CM, Allen BC, et al
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
    Radiology. 2019;292:226-234.
    PubMed     Abstract available


    June 2019
  90. MILOT L
    Does Hepatocellular Carcinoma Screening with US Work? Using the US LI-RADS Algorithm.
    Radiology. 2019 Jun 18:191105. doi: 10.1148/radiol.2019191105.
    PubMed    


  91. SON JH, Choi SH, Kim SY, Jang HY, et al
    Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Radiology. 2019 Jun 18:190035. doi: 10.1148/radiol.2019190035.
    PubMed     Abstract available


  92. PADIA SA
    Is Idarubicin the Future of TACE?
    Radiology. 2019;291:809-810.
    PubMed    


  93. FOWLER KJ, Sirlin CB
    Is It Time to Expand the Definition of Washout Appearance in LI-RADS?
    Radiology. 2019;291:658-659.
    PubMed    


    May 2019
  94. MALLOY PC
    Combination Therapy in Intermediate-Stage Hepatocellular Carcinoma: Do We Need to Know about Microvascular Invasion?
    Radiology. 2019 May 28:190921. doi: 10.1148/radiol.2019190921.
    PubMed    


  95. PENG Z, Chen S, Xiao H, Wang Y, et al
    Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Radiology. 2019 May 28:181818. doi: 10.1148/radiol.2019181818.
    PubMed     Abstract available


  96. AMBALE-VENKATESH B, Lima JAC
    Probing the Liver-Heart Axis.
    Radiology. 2019;291:338-339.
    PubMed    


    April 2019
  97. GUIU B, Chevallier P, Assenat E, Barbier E, et al
    Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
    Radiology. 2019 Apr 30:182399. doi: 10.1148/radiol.2019182399.
    PubMed     Abstract available


  98. KIM DH, Choi SH, Kim SY, Kim MJ, et al
    Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases.
    Radiology. 2019 Apr 16:182587. doi: 10.1148/radiol.2019182587.
    PubMed     Abstract available


  99. FURLAN A
    New Progress toward Validation of LI-RADS Version 2018.
    Radiology. 2019;291:81-82.
    PubMed    


    March 2019
  100. VITA T, Murphy DJ, Osborne MT, Bajaj NS, et al
    Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
    Radiology. 2019 Mar 5:181793. doi: 10.1148/radiol.2019181793.
    PubMed     Abstract available


  101. LUCATELLI P, De Rubeis G, Rocco B, Bezzi M, et al
    Are Radiopaque Beads a Real Advantage?
    Radiology. 2019;290:852-853.
    PubMed    


    January 2019
  102. KIM YY, Kim MJ, Kim EH, Roh YH, et al
    Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.
    Radiology. 2019 Jan 29:181995. doi: 10.1148/radiol.2019181995.
    PubMed     Abstract available


  103. HEERINK WJ, Ruiter SJS, Pennings JP, Lansdorp B, et al
    Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial.
    Radiology. 2019 Jan 22:181698. doi: 10.1148/radiol.2018181698.
    PubMed     Abstract available


  104. GRAY MD, Lyon PC, Mannaris C, Folkes LK, et al
    Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
    Radiology. 2019 Jan 15:181445. doi: 10.1148/radiol.2018181445.
    PubMed     Abstract available


  105. YOON JH, Lee JM
    Can MRI Features Predict Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma?
    Radiology. 2019 Jan 8:182775. doi: 10.1148/radiol.2018182775.
    PubMed    


  106. MIN JH, Kim YK, Choi SY, Kang TW, et al
    Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Radiology. 2019 Jan 8:181485. doi: 10.1148/radiol.2018181485.
    PubMed     Abstract available


    December 2018
  107. POOLER BD, Wiens CN, McMillan A, Artz NS, et al
    Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.
    Radiology. 2018 Dec 18:181134. doi: 10.1148/radiol.2018181134.
    PubMed     Abstract available


  108. WESTON AD, Korfiatis P, Kline TL, Philbrick KA, et al
    Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning.
    Radiology. 2018 Dec 11:181432. doi: 10.1148/radiol.2018181432.
    PubMed     Abstract available


  109. CURTIS WA, Fraum TJ, An H, Chen Y, et al
    Quantitative MRI of Diffuse Liver Disease: Current Applications and Future Directions.
    Radiology. 2018 Dec 4:172765. doi: 10.1148/radiol.2018172765.
    PubMed     Abstract available


  110. PARK HJ, Lee SS, Park B, Yun J, et al
    Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.
    Radiology. 2018 Dec 4:181197. doi: 10.1148/radiol.2018181197.
    PubMed     Abstract available


    November 2018
  111. JENSEN CT, Wagner-Bartak NA, Vu LN, Liu X, et al
    Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
    Radiology. 2018 Nov 27:181657. doi: 10.1148/radiol.2018181657.
    PubMed     Abstract available


  112. QI X, An W, Liu F, Qi R, et al
    Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
    Radiology. 2018 Nov 20:180425. doi: 10.1148/radiol.2018180425.
    PubMed     Abstract available


  113. MALAYERI AA
    Virtual Hepatic Venous Pressure Gradient with CT: Ready for Prime Time?
    Radiology. 2018 Nov 20:182351. doi: 10.1148/radiol.2018182351.
    PubMed    


  114. BASHIR MR, Chernyak V
    Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
    Radiology. 2018 Nov 13:182408. doi: 10.1148/radiol.2018182408.
    PubMed    


  115. CHOI SH, Lee SS, Park SH, Kim KM, et al
    LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
    Radiology. 2018 Nov 13:181290. doi: 10.1148/radiol.2018181290.
    PubMed     Abstract available


    October 2018
  116. YOON JH, Lee JM, Kang HJ, Ahn SJ, et al
    Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
    Radiology. 2018 Oct 30:180753. doi: 10.1148/radiol.2018180753.
    PubMed     Abstract available


  117. MOTOSUGI U, Roldan-Alzate A, Bannas P, Said A, et al
    Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.
    Radiology. 2018 Oct 16:180230. doi: 10.1148/radiol.2018180230.
    PubMed     Abstract available


  118. KHALAF MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, et al
    A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Radiology. 2018 Oct 9:180257. doi: 10.1148/radiol.2018180257.
    PubMed     Abstract available


    September 2018
  119. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    PubMed     Abstract available


  120. FLETCHER JG, Fidler JL, Venkatesh S, Hough DM, et al
    Observer Performance with Varying Radiation Dose and Reconstruction Methods for Detection of Hepatic Metastases.
    Radiology. 2018 Sep 11:180125. doi: 10.1148/radiol.2018180125.
    PubMed     Abstract available


  121. SARTORIS R, Rautou PE, Elkrief L, Pollorsi G, et al
    Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Radiology. 2018 Sep 4:181131. doi: 10.1148/radiol.2018181131.
    PubMed     Abstract available


  122. BASTIAANNET R, van Roekel C, Kunnen B, Lam MGEH, et al
    Is Diffusion-weighted MRI Really Superior to PET/CT in Predicting Survival after Radioembolization?
    Radiology. 2018 Sep 4:181348. doi: 10.1148/radiol.2018181348.
    PubMed    


  123. SMITH AD
    Enter the Era of Quantitative Liver CT.
    Radiology. 2018 Sep 4:181847. doi: 10.1148/radiol.2018181847.
    PubMed    


  124. CHOI KJ, Jang JK, Lee SS, Sung YS, et al
    Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver.
    Radiology. 2018 Sep 4:180763. doi: 10.1148/radiol.2018180763.
    PubMed     Abstract available


    August 2018
  125. PANDEY A, Pandey P, Ghasabeh MA, Zarghampour M, et al
    Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Radiology. 2018 Aug 21:180450. doi: 10.1148/radiol.2018180450.
    PubMed     Abstract available


  126. CHUNG JW, Kim HC
    Can CT Following Chemoembolization with Radiopaque Drug-Eluting Beads Tell Us How Much Drug We Deliver?
    Radiology. 2018 Aug 14:181275. doi: 10.1148/radiol.2018181275.
    PubMed    


  127. MIKHAIL AS, Pritchard WF, Negussie AH, Krishnasamy VP, et al
    Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
    Radiology. 2018 Aug 14:172571. doi: 10.1148/radiol.2018172571.
    PubMed     Abstract available


    July 2018
  128. BARR RG
    Liver Elastography Still in Its Infancy.
    Radiology. 2018;288:107-108.
    PubMed    


  129. HUDERT CA, Tzschatzsch H, Guo J, Rudolph B, et al
    US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Radiology. 2018;288:99-106.
    PubMed     Abstract available


    June 2018
  130. LUETKENS JA, Klein S, Traber F, Schmeel FC, et al
    Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.
    Radiology. 2018 Jun 26:180051. doi: 10.1148/radiol.2018180051.
    PubMed     Abstract available


  131. JOHNSON PT, Fishman EK
    Hereditary Hemorrhagic Telangiectasia: Cinematic Rendering of Hepatic Arteriovenous Malformations.
    Radiology. 2018 Jun 19:180380. doi: 10.1148/radiol.2018180380.
    PubMed    


  132. HEVERHAGEN JT, Kudrnova S
    Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
    Radiology. 2018 Jun 19:180977. doi: 10.1148/radiol.2018180977.
    PubMed    


  133. SONG KD, Lee MW, Rhim H, Kang TW, et al
    Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Radiology. 2018 Jun 19. doi: 10.1148/radiol.2018172743.
    PubMed     Abstract available


  134. BREHMER K, Brismar TB, Morsbach F, Svensson A, et al
    Triple Arterial Phase CT of the Liver with Radiation Dose Equivalent to That of Single Arterial Phase CT: Initial Experience.
    Radiology. 2018 Jun 19:172875. doi: 10.1148/radiol.2018172875.
    PubMed     Abstract available


  135. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    PubMed     Abstract available


  136. FANG C, Jaffer OS, Yusuf GT, Konstantatou E, et al
    Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice.
    Radiology. 2018;287:844-852.
    PubMed     Abstract available


  137. TROUT AT, Sheridan RM, Serai SD, Xanthakos SA, et al
    Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.
    Radiology. 2018;287:824-832.
    PubMed     Abstract available


    May 2018
  138. BARABASCH A, Heinzel A, Bruners P, Kraemer NA, et al
    Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing (90)Y Radioembolization of Hepatic Metastases.
    Radiology. 2018 May 21:170408. doi: 10.1148/radiol.2018170408.
    PubMed     Abstract available


  139. DEVULAPALLI KK, Fidelman N, Soulen MC, Miller M, et al
    (90)Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
    Radiology. 2018 May 8:170962. doi: 10.1148/radiol.2018170962.
    PubMed     Abstract available


  140. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.
    Radiology. 2018 May 8:172944. doi: 10.1148/radiol.2018172944.
    PubMed     Abstract available


  141. CROCETTI L
    Radiofrequency Ablation versus Resection for Small Hepatocellular Carcinoma: Are Randomized Controlled Trials Still Needed?
    Radiology. 2018;287:473-475.
    PubMed    


  142. POMPER MG, Lee S
    Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.
    Radiology. 2018;287:590-591.
    PubMed    


    April 2018
  143. SOFOCLEOUS CT, Boas FE
    Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?
    Radiology. 2018 Apr 24:180163. doi: 10.1148/radiol.2018180163.
    PubMed    


  144. LEWANDOWSKI RJ, Gabr A, Abouchaleh N, Ali R, et al
    Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.
    Radiology. 2018 Apr 24:171768. doi: 10.1148/radiol.2018171768.
    PubMed     Abstract available


  145. ZHU K, Huang J, Lai L, Huang W, et al
    Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Apr 24:172028. doi: 10.1148/radiol.2018172028.
    PubMed     Abstract available


  146. CERNY M, Bergeron C, Billiard JS, Murphy-Lavallee J, et al
    LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features.
    Radiology. 2018 Apr 10:171678. doi: 10.1148/radiol.2018171678.
    PubMed     Abstract available


  147. SHYN PB, Casadaban LC, Sainani NI, Sadow CA, et al
    Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Radiology. 2018 Apr 3:172108. doi: 10.1148/radiol.2018172108.
    PubMed     Abstract available


  148. WANG X, Su Z, Lyu T, Figini M, et al
    (18)F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
    Radiology. 2018;287:137-145.
    PubMed     Abstract available


    March 2018
  149. MULE S, Thiefin G, Costentin C, Durot C, et al
    Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Radiology. 2018 Mar 27:171320. doi: 10.1148/radiol.2018171320.
    PubMed     Abstract available


  150. PANDEY A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, et al
    Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
    Radiology. 2018 Mar 27:171593. doi: 10.1148/radiol.2018171593.
    PubMed     Abstract available


  151. TA CN, Kono Y, Eghtedari M, Oh YT, et al
    Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings.
    Radiology. 2018;286:1062-1071.
    PubMed     Abstract available


    February 2018
  152. CHOI SH, Byun JH, Lim YS, Lee SJ, et al
    Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.
    Radiology. 2018 Feb 19:170748. doi: 10.1148/radiol.2018170748.
    PubMed     Abstract available


  153. PENG Z, Chen S, Wei M, Lin M, et al
    Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Feb 1:171541. doi: 10.1148/radiol.2018171541.
    PubMed     Abstract available


  154. MURALI N, Laage-Gaupp FM, Chapiro J, Geschwind JF, et al
    Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?
    Radiology. 2018;286:405-408.
    PubMed     Abstract available


  155. BOESCH C
    Quantitative MR Imaging Is Increasingly Important in Liver Disease.
    Radiology. 2018;286:557-559.
    PubMed    


    January 2018
  156. KWEE SA, Wong L, Chan OTM, Kalathil S, et al
    PET/CT with (18)F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.
    Radiology. 2018 Jan 9:171333. doi: 10.1148/radiol.2018171333.
    PubMed     Abstract available


  157. LEE DH, Lee JM, Kang TW, Rhim H, et al
    Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.
    Radiology. 2018;286:338-349.
    PubMed     Abstract available


    December 2017
  158. YU SCH, Chan SL, Lee KF, Hui JWY, et al
    Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
    Radiology. 2017 Dec 22:170154. doi: 10.1148/radiol.2017170154.
    PubMed     Abstract available


  159. YASAKA K, Akai H, Kunimatsu A, Abe O, et al
    Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Radiology. 2017 Dec 14:171928. doi: 10.1148/radiol.2017171928.
    PubMed     Abstract available


  160. SANDOW TA, Arndt SE, Albar AA, DeVun DA, et al
    Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort.
    Radiology. 2017 Dec 4:170731. doi: 10.1148/radiol.2017170731.
    PubMed     Abstract available


  161. SHAMIR SB, Kurian J, Kogan-Liberman D, Taragin BH, et al
    Hepatic Imaging in Neonates and Young Infants: State of the Art.
    Radiology. 2017;285:763-777.
    PubMed     Abstract available


  162. YANG X
    Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.
    Radiology. 2017;285:699-701.
    PubMed     Abstract available


  163. WHITE SB, Kim DH, Guo Y, Li W, et al
    Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
    Radiology. 2017;285:809-819.
    PubMed     Abstract available


    November 2017
  164. CHOI SY, Kim SH, Park CK, Min JH, et al
    Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Radiology. 2017 Nov 21:162846. doi: 10.1148/radiol.2017162846.
    PubMed     Abstract available


  165. TANG A, Bashir MR, Corwin MT, Cruite I, et al
    Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Radiology. 2017 Nov 21:170554. doi: 10.1148/radiol.2017170554.
    PubMed     Abstract available


  166. FARRAR CT, Gale EM, Kennan R, Ramsay I, et al
    CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis.
    Radiology. 2017 Nov 20:170595. doi: 10.1148/radiol.2017170595.
    PubMed     Abstract available


  167. XU XL, Liu XD, Liang M, Luo BM, et al
    Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.
    Radiology. 2017 Nov 13:162756. doi: 10.1148/radiol.2017162756.
    PubMed     Abstract available


  168. SEROR O, Nault JC, N'Kontchou G, Sutter O, et al
    Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental 90Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?
    Radiology. 2017;285:690-691.
    PubMed    


  169. ADAM LC, Murali N, Chapiro J, Geschwind JF, et al
    Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?
    Radiology. 2017;285:333-335.
    PubMed     Abstract available


  170. YAN F, Wang S, Yang W, Goldberg SN, et al
    Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Radiology. 2017;285:462-471.
    PubMed     Abstract available


  171. FOWLER KJ, Tang A, Santillan C, Bhargavan-Chatfield M, et al
    Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
    Radiology. 2017 Nov 1:170376. doi: 10.1148/radiol.2017170376.
    PubMed     Abstract available


    October 2017
  172. YASAKA K, Akai H, Abe O, Kiryu S, et al
    Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.
    Radiology. 2017 Oct 27:170706. doi: 10.1148/radiol.2017170706.
    PubMed     Abstract available


    September 2017
  173. WANG WT, Yang L, Yang ZX, Hu XX, et al
    Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.
    Radiology. 2017 Sep 22:170515. doi: 10.1148/radiol.2017170515.
    PubMed     Abstract available


  174. RUNGE JH, Smits LP, Verheij J, Depla A, et al
    MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Radiology. 2017 Sep 15:162931. doi: 10.1148/radiol.2017162931.
    PubMed     Abstract available


  175. YOKOO T, Serai SD, Pirasteh A, Bashir MR, et al
    Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
    Radiology. 2017 Sep 11:170550. doi: 10.1148/radiol.2017170550.
    PubMed     Abstract available


  176. KUMAR G, Goldberg SN, Gourevitch S, Levchenko T, et al
    Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
    Radiology. 2017 Sep 6:162943. doi: 10.1148/radiol.2017162943.
    PubMed     Abstract available


    August 2017
  177. FRAUM TJ, Tsai R, Rohe E, Ludwig DR, et al
    Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
    Radiology. 2017 Aug 29:170114. doi: 10.1148/radiol.2017170114.
    PubMed     Abstract available


  178. DISTELMAIER M, Barabasch A, Heil P, Kraemer NA, et al
    Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Radiology. 2017 Aug 11:161561. doi: 10.1148/radiol.2017161561.
    PubMed     Abstract available


  179. RONALD J, Nixon AB, Marin D, Gupta RT, et al
    Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
    Radiology. 2017 Aug 8:162555. doi: 10.1148/radiol.2017162555.
    PubMed     Abstract available


  180. WAGNER M, Corcuera-Solano I, Lo G, Esses S, et al
    Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study.
    Radiology. 2017;284:401-412.
    PubMed     Abstract available


    July 2017
  181. LV Y, He C, Wang Z, Guo W, et al
    Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
    Radiology. 2017 Jul 5:162266. doi: 10.1148/radiol.2017162266.
    PubMed     Abstract available


  182. LEE JM
    Old and New MR Tools to Measure Hepatic Steatosis: Is Their Diagnostic Accuracy the Same?
    Radiology. 2017;284:303-304.
    PubMed    


  183. HARZ C, Schockel L, Endrikat J, Pietsch H, et al
    Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.
    Radiology. 2017;284:299-301.
    PubMed    


    June 2017
  184. KIM BR, Lee JM, Lee DH, Yoon JH, et al
    Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
    Radiology. 2017 Jun 13:162080. doi: 10.1148/radiol.2017162080.
    PubMed     Abstract available


  185. LEE DH, Lee JY, Lee KB, Han JK, et al
    Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy.
    Radiology. 2017 Jun 13:161923. doi: 10.1148/radiol.2017161923.
    PubMed     Abstract available


  186. GOSHIMA S, Bae KT
    Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.
    Radiology. 2017;283:921-922.
    PubMed    


  187. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Radiology. 2017;283:923.
    PubMed    


  188. SAVIC LJ, Chapiro J, Geschwind JF
    Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?
    Radiology. 2017;283:621-623.
    PubMed     Abstract available


  189. GARCOVICH M, Veraldi S, Di Stasio E, Zocco MA, et al
    Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.
    Radiology. 2017;283:820-827.
    PubMed     Abstract available


    May 2017
  190. KAO WY, Su CW, Chiou YY, Chiu NC, et al
    Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
    Radiology. 2017 May 30:162382. doi: 10.1148/radiol.2017162382.
    PubMed     Abstract available


  191. WIDYA RL, de Mutsert R, Westenberg JJM, Gast KB, et al
    Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study.
    Radiology. 2017 May 29:160916. doi: 10.1148/radiol.2017160916.
    PubMed     Abstract available


  192. LEE KS, Santagostino SF, Li D, Ramjit A, et al
    Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.
    Radiology. 2017 May 11:162617. doi: 10.1148/radiol.2017162617.
    PubMed     Abstract available


  193. KUHN JP, Meffert P, Heske C, Kromrey ML, et al
    Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Radiology. 2017 May 5. doi: 10.1148/radiol.2017161228.
    PubMed     Abstract available


    April 2017
  194. SUTTER O, Calvo J, N'Kontchou G, Nault JC, et al
    Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Radiology. 2017 Apr 28:161413. doi: 10.1148/radiol.2017161413.
    PubMed     Abstract available


  195. CHEN R, Li J, Zhou X, Liu J, et al
    Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.
    Radiology. 2017 Apr 6:161607. doi: 10.1148/radiol.2017161607.
    PubMed     Abstract available


  196. ETCHELL E, Juge L, Hatt A, Sinkus R, et al
    Liver Stiffness Values Are Lower in Pediatric Subjects than in Adults and Increase with Age: A Multifrequency MR Elastography Study.
    Radiology. 2017;283:222-230.
    PubMed     Abstract available


    March 2017
  197. PULLI B, Wojtkiewicz G, Iwamoto Y, Ali M, et al
    Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Radiology. 2017 Mar 30:160588. doi: 10.1148/radiol.2017160588.
    PubMed     Abstract available


  198. PARK MJ, Hong N, Han K, Kim MJ, et al
    Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Radiology. 2017 Mar 22:161619. doi: 10.1148/radiol.2017161619.
    PubMed     Abstract available


    February 2017
  199. HYODO T, Yada N, Hori M, Maenishi O, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation.
    Radiology. 2017 Feb 17:160130. doi: 10.1148/radiol.2017160130.
    PubMed     Abstract available


  200. SOLOMON J, Marin D, Roy Choudhury K, Patel B, et al
    Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Rec
    Radiology. 2017 Feb 7:161736. doi: 10.1148/radiol.2017161736.
    PubMed     Abstract available


  201. MICHEL LS, Dyroff S, Brooks FJ, Spayd KJ, et al
    PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
    Radiology. 2017;282:453-463.
    PubMed     Abstract available


    December 2016
  202. KIM YK, Lin WC, Sung K, Raman SS, et al
    Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
    Radiology. 2016 Dec 15:160241.
    PubMed     Abstract available


  203. BELLINI D, Ramirez-Giraldo JC, Bibbey A, Solomon J, et al
    Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation.
    Radiology. 2016 Dec 5:161233.
    PubMed     Abstract available


    November 2016
  204. SAHU S, Schernthaner R, Ardon R, Chapiro J, et al
    Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Radiology. 2016 Nov 10:160838.
    PubMed     Abstract available


    October 2016
  205. SERAI SD, Dillman JR, Trout AT
    Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Young Adults Suspected of Having Liver Disease.
    Radiology. 2016 Oct 10:160589.
    PubMed     Abstract available


    August 2016
  206. HYODO T, Hori M, Lamb P, Sasaki K, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.
    Radiology. 2016 Aug 19:160129.
    PubMed     Abstract available


    June 2016
  207. TROUT AT, Serai S, Mahley AD, Wang H, et al
    Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences.
    Radiology. 2016 Jun 10:160209.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: